Huadong Pharmaceutical Group 3.1 antifungal drug kapofungin acetate applied for production accepted
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
According to the information on April 3 on the website of the State Food and Drug Administration (CFDA), the application for the production of 3.1 antifungal drug kapofen acetate was accepted According to the public information, kapofungin acetate is suitable for the treatment of invasive aspergillosis that is ineffective or intolerable to other treatments, as well as for the suspected fungal infection of people with neutropenia and fever The original research drug is "Kosis" developed by MSD, which entered the Chinese market in 2009 CFDA shows that at present, only the original research drug is on sale in China, and there is no domestic enterprise producing kapofungin acetate API and related preparations In addition to Huadong pharmaceutical, Hengrui Pharmaceutical (600276 SH) has applied for the production approval documents of carbaryl acetate API and injection, and aosaikang has applied for the production approval documents of API East China medicine is the leading double ingredient in the field of immunity and hypoglycemic drugs in China The field of anti severe infection, anti-tumor and cardiovascular is the new field that the company will focus on in the next three years.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
